NASDAQ: ACRS       Aclaris Therapts
Last Price Today's Change   Day's Range   Trading Volume
1.69   -0.09 (5.06%)  1.68 - 1.77  107,972


Avg Volume (4 weeks):1,150,775
4 Weeks Range:1.48 - 2.00
4 Weeks Price Volatility (%):
52 Weeks Range:0.74 - 9.75
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which operates in United States. It focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology. The company holds a drug candidate, A-101 Topical Solution which is a proprietary high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis (SK) a common non-malignant skin tumor. Its pipeline of drug candidates includes A-101 as a Topical Solution for treatment of SK, common warts; A-102 as a gel dosage form for treatment of SK and warts and A-201 and A-301 as an oral and topical formulation for treatment of autoimmune dermatologic respectively.

  Be the first to like this.


1661  3853  556  2907 

Top 10 Active Counters
 CELG 108.24+0.11 
 ACB 3.09+0.45 
 AABA 19.630.00 
 AMD 39.416-1.564 
 UBER 29.075+1.045 
 CHK 0.576+0.006 
 SCHW 48.215+3.465 
 M 14.67-0.35 
 GGB 3.755+0.155 
 HEPA 3.60+1.18 
Partners & Brokers